WASHINGTON & ROCHESTER, Minn. & NIJMEGEN, Netherlands & DUISBURG, Germany--(BUSINESS WIRE)--
Exciting, new, patented technology platform poised to disrupt diabetes care delivery globally
Extremely low-cost, pain-free system could be a game changer
No more lancets, glucometers
Real-time cloud-based readings deliverable to caregivers and providers anywhere instantly via NFC cell phones
Opportunity to improve diabetes outcomes worldwide
Building on the long-standing collaboration between Gentag and Mayo Clinic, and the long-standing collaboration between NovioSense and Fraunhofer Institute for Microelectronic Circuits and Systems (IMS), Gentag and NovioSense today announced that they have formed a joint venture to combat the epidemic of type 2 diabetes that is overwhelming people and health care systems worldwide.
Help employers find you! Check out all the jobs and post your resume.
